Rate per 100,000 Population of Reported Cases* by Age Group - 2013

  <1 1-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60+ Total
AIDS** 0.9 0.0 0.0 0.7 7.1 34.3 46.8 58.3 41.4 13.6 29.0
AMEBIASIS 0.8 2.6 3.7 2.8 1.6 5.1 6.7 8.6 6.0 2.4 4.9
ANAPLASMOSIS 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.3
BABESIOSIS 0.0 0.0 0.0 0.2 0.4 0.1 0.2 0.7 1.3 3.0 0.9
BOTULISM 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.04
CAMPYLOBACTERIOSIS 139.2 87.1 28.6 19.6 21.2 18.6 15.5 10.7 9.2 12.0 20.8
CHLAMYDIA NA NA NA 140.1 3052.6 2125.6 641.5 245.0 92.3 17.3 696.9
CRYPTOSPORIDIOSIS 0.0 1.2 0.4 0.6 0.2 1.1 1.8 1.7 0.9 0.1 1.0
CYCLOSPORA 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.2 0.1 0.2
DENGUE FEVER 0.0 0.5 0.6 2.6 2.0 1.6 1.2 1.7 2.6 1.8 1.7
E. COLI 0157 0.8 1.6 0.6 0.6 0.4 0.1 0.1 0.1 0.0 0.3 0.3
EHEC*** 1.7 7.0 0.6 1.3 1.0 0.1 0.3 0.3 0.2 0.5 0.8
EHRLICHIOSIS 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.3 0.5 0.2
ENCEPHALITIS (NON-WESTNILE)**** 0.0 0.5 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.1
GIARDIASIS 1.7 15.9 14.1 6.9 5.2 11.1 12.5 11.0 6.3 4.4 9.2
GONORRHEA NA NA NA 28.6 485.3 479.4 208.8 94.8 35.7 4.9 161.9
HAEMOPHILUS INFLUENZAE 5.9 1.2 0.4 0.6 0.6 0.1 0.7 0.8 1.2 3.5 1.3
HEMOLYTIC UREMIC SYNDROME 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.05
HEPATITIS A 0.0 0.2 0.6 0.6 1.2 2.3 1.7 0.9 0.9 0.5 1.1
HEPATITIS B - ACUTE 0.0 0.0 0.0 0.0 0.0 0.6 1.1 1.9 1.6 0.5 0.8
HEPATITIS C - ACUTE 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.2 0.3 0.1 0.2
HIV***** 2.6 0.0 0.0 1.1 26.4 77.3 60.1 50.8 28.2 11.0 36.4
LABORATORY CONFIRMED INFLUENZA 871.1 495.9 343.0 135.3 84.2 83.3 82.5 72.7 76.9 150.0 144.2
LEGIONELLOSIS 0.0 0.0 0.0 0.0 0.0 0.6 0.9 3.4 8.3 10.5 3.6
LISTERIOSIS 1.7 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.4 1.4 0.4
LYME DISEASE 0.0 6.1 11.6 10.8 8.3 6.2 7.9 7.9 11.1 11.8 8.9
LYMPHOGRANULOMA VENEREUM NA NA NA 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1
MALARIA 0.0 2.3 2.7 2.8 2.6 2.7 2.1 3.1 3.1 1.0 2.4
MEASLES 11.0 4.7 1.5 1.3 1.4 0.4 0.2 0.1 0.0 0.0 0.7
MENINGITIS ASEPTIC 46.7 2.3 3.7 3.0 3.8 2.6 2.4 2.9 1.6 2.2 3.2
MENINGOCOCCAL 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.1 0.4 0.1 0.2
MENINGITIS OTHER BACTERIAL 24.6 0.9 0.2 1.1 0.6 1.4 1.1 1.3 2.0 2.4 1.8
MUMPS 2.5 0.0 0.0 0.2 0.2 1.1 0.5 0.4 0.0 0.2 0.4
PERTUSSIS 39.9 4.7 3.1 2.8 0.8 0.6 0.9 1.0 0.5 0.3 1.7
RMSF 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.02
RUBELLA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.01
SALMONELLOSIS 142.6 68.8 22.4 9.7 7.3 8.5 4.9 6.3 6.1 11.2 13.6
SHIGELLOSIS 5.1 12.2 5.6 2.2. 3.0 3.7 4.1 4.2 2.6 1.9 3.8
STREP GROUP A INVASIVE 5.9 1.2 2.1 0.4 0.4 1.4 2.7 1.8 3.6 5.8 2.7
STREP PNEUMONIA INVASIVE 10.2 7.0 1.7 1.1 1.4 1.9 3.4 6.1 14.9 21.3 8.1
SYPHILIS EARLY NA NA NA 0.4 13.1 61.3 68.1 65.7 25.8 6.1 34.9
SYPHILIS LATE NA NA NA 0.4 12.5 40.2 45.7 51.2 22.3 15.6 26.7
TOXIC SHOCK SYNDROME 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.04
TUBERCULOSIS 1.7 0.7 0.6 1.5 4.8 7.7 9.7 9.3 8.8 12.6 7.9
TYPHOID FEVER 0.8 0.9 0.2 0.6 0.6 0.3 0.3 0.2 0.0 0.1 0.3
WEST NILE FEVER 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.02
WEST NILE VIRUS 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.1
YERSINIOSIS 0.8 0.7 0.0 0.0 0.2 0.3 0.2 0.1 0.1 0.3 0.2

Footnotes

  • *Based on year diagnosed
  • **Based on year reported (excludes inmates). Includes all newly-reports AIDS cases regardless of HIV diagnosis date.
    Provisional, data as of July 7, 2014. County of residence is unknown for 9 cases.
  • ***E.coli non-O157 and non-sero-grouped shigatoxin producing infection
  • ****A change in surveillance is responsible for the decline in the number of encephalitis cases.
    As of 2013, laboratory requisitions are no longer being used to approximate cases of encephalitis.
  • *****Based on year reported (excludes inmates). Includes all newly-reported HIV cases, regardless of concurrent or subsequent AIDS diagnosis.
    Provisional, data as of July 7, 2014.